S. Sigurdsson, S. Thorlacius, J. Tomasson, L. Tryggvadottir, K. Benediktsdottir, J. Eyfjord, E. Jonsson (1997)
BRCA2 mutation in Icelandic prostate cancer patientsJournal of Molecular Medicine, 75
C. Haiman, N. Patterson, M. Freedman, S. Myers, M. Pike, Alicja Waliszewska, Julie Neubauer, Arti Tandon, Christine Schirmer, G. McDonald, S. Greenway, D. Stram, L. Marchand, L. Kolonel, M. Frasco, David Wong, Loreall Pooler, K. Ardlie, I. Oakley-Girvan, A. Whittemore, K. Cooney, E. John, S. Ingles, D. Altshuler, B. Henderson, D. Reich (2007)
Multiple regions within 8q24 independently affect risk for prostate cancerNature Genetics, 39
N. Dubin, B. Pasternack (1986)
Risk assessment for case-control subgroups by polychotomous logistic regression.American journal of epidemiology, 123 6
(1999)
Cancer Risks in BRCA 2 Mutation Carriers The Breast Cancer Linkage Consortium
A. Armuzzi, Tariq Ahmad, K. Ling, A. Silva, S. Cullen, D. Heel, T. Orchard, K. Welsh, S. Marshall, D. Jewell (2003)
Genotype-phenotype analysis of the Crohn’s disease susceptibility haplotype on chromosome 5q31Journal of Medical Genetics, 40
D. Bruner, D. Moore, Alicia Parlanti, J. Dorgan, P. Engstrom (2003)
Relative risk of prostate cancer for men with affected relatives: Systematic review and meta‐analysisInternational Journal of Cancer, 107
J. Struewing, P. Hartge, S. Wacholder, Sonya Baker, M. Berlin, M. McAdams, Michelle Timmerman, L. Brody, Margaret Tucker (1997)
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.The New England journal of medicine, 336 20
U. Dailey
Cancer,Facts and Figures about.Journal of the National Medical Association, 14 1
S. Powell, N. Zilz, Y. Beazer-Barclay, T. Bryan, S. Hamilton, S. Thibodeau, B. Vogelstein, K. Kinzler (1992)
APC mutations occur early during colorectal tumorigenesisNature, 359
K. Nastiuk, M. Mansukhani, M. Terry, P. Kularatne, M. Rubin, J. Melamed, M. Gammon, M. Ittmann, J. Krolewski (1999)
Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish menThe Prostate, 40
Colleen Sinclair, R. Berry, D. Schaid, S. Thibodeau, F. Couch (2000)
BRCA1 and BRCA2 have a limited role in familial prostate cancer.Cancer research, 60 5
H. Eerola, E. Pukkala, S. Pyrhönen, C. Blomqvist, R. Sankila, H. Nevanlinna (2001)
Risk of cancer in BRCA1 and BRCA2 mutation-positive and -negative breast cancer families (Finland)Cancer Causes & Control, 12
(2009)
American Association for Cancer clincancerres.aacrjournals.org Downloaded from www
O. Johannsson, N. Loman, Torgil Möller, Ulf Kristoffersson, Åke Borg, Håkan Olsson (1999)
Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers.European journal of cancer, 35 8
I. Agalliu, E. Karlins, E. Kwon, Lori Iwasaki, A. Diamond, E. Ostrander, J. Stanford (2007)
Rare germline mutations in the BRCA2 gene are associated with early-onset prostate cancerBritish Journal of Cancer, 97
H. Tulinius, G. Olafsdóttir, H. Sigvaldason, A. Arason, R. Barkardottir, V. Egilsson, H. Ögmundsdóttir, L. Tryggvadottir, S. Gudlaugsdottir, J. Eyfjord (2002)
The effect of a single BRCA2 mutation on cancer in IcelandJournal of Medical Genetics, 39
F. Fodor, A. Weston, I. Bleiweiss, L.D. McCurdy, M. Walsh, P. Tartter, S. Brower, C. Eng (1998)
Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients.American journal of human genetics, 63 1
L. Amundadottir, P. Sulem, J. Gudmundsson, Agnar Helgason, A. Baker, B. Agnarsson, A. Sigurdsson, K. Benediktsdottir, J. Cazier, J. Sainz, Margret Jakobsdottir, J. Kostic, Droplaug Magnúsdóttir, Shyamali Ghosh, Kari Agnarsson, B. Birgisdottir, L. Roux, A. Ólafsdóttir, T. Blondal, M. Andrésdóttir, Ó. Grétarsdóttir, J. Bergthórsson, D. Gudbjartsson, Arnaldur Gylfason, G. Thorleifsson, A. Manolescu, K. Kristjánsson, G. Geirsson, H. Isaksson, J. Douglas, J. Johansson, K. Bälter, F. Wiklund, J. Montie, Xiaoying Yu, B. Suarez, C. Ober, K. Cooney, H. Gronberg, W. Catalona, G. Einarsson, R. Barkardottir, J. Gulcher, A. Kong, U. Thorsteinsdóttir, K. Stefánsson (2006)
A common variant associated with prostate cancer in European and African populationsNature Genetics, 38
P. Hartge, J. Struewing, S. Wacholder, L. Brody, Margaret Tucker (1999)
The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews.American journal of human genetics, 64 4
Bethesda (MD): National Cancer Institute
Deborah Thompson, D. Easton (2002)
Cancer Incidence in BRCA1 mutation carriers.Journal of the National Cancer Institute, 94 18
S. Edwards, Z. Kote-Jarai, J. Meitz, R. Hamoudi, Q. Hope, P. Osin, R. Jackson, C. Southgate, Rashmi Singh, A. Falconer, D. Dearnaley, A. Ardern-jones, A. Murkin, A. Dowe, J. Kelly, Sue Williams, R. Oram, Margaret Stevens, D. Teare, B. Ponder, S. Gayther, D. Easton, R. Eeles (2003)
Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene.American journal of human genetics, 72 1
H. Risch, J. McLaughlin, D. Cole, B. Rosen, L. Bradley, I. Fan, James Tang, Song Li, Shiyu Zhang, P. Shaw, S. Narod (2006)
Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada.Journal of the National Cancer Institute, 98 23
A. Willems, S. Dawson, H. Samaratunga, A. Luca, Y. Antill, J. Hopper, H. Thorne (2008)
Loss of Heterozygosity at the BRCA2 Locus Detected by Multiplex Ligation-Dependent Probe Amplification is Common in Prostate Cancers from Men with a Germline BRCA2 MutationClinical Cancer Research, 14
J. Bermejo, K. Hemminki (2004)
Risk of cancer at sites other than the breast in Swedish families eligible for BRCA1 or BRCA2 mutation testing.Annals of oncology : official journal of the European Society for Medical Oncology, 15 12
M. Yeager, N. Orr, R. Hayes, K. Jacobs, P. Kraft, S. Wacholder, Mark Minichiello, P. Fearnhead, Kai Yu, N. Chatterjee, Zhaoming Wang, R. Welch, B. Staats, E. Calle, H. Feigelson, M. Thun, C. Rodríguez, D. Albanes, J. Virtamo, S. Weinstein, F. Schumacher, E. Giovannucci, W. Willett, G. Cancel-Tassin, O. Cussenot, A. Valéri, G. Andriole, E. Gelmann, M. Tucker, D. Gerhard, J. Fraumeni, R. Hoover, D. Hunter, S. Chanock, G. Thomas (2007)
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24Nature Genetics, 39
Eric Wilkens, D. Freije, Jianfeng Xu, D. Nusskern, Hiroyoshi Suzuki, S. Isaacs, K. Wiley, P. Bujnovszky, D. Meyers, P. Walsh, W. Isaacs (1999)
No evidence for a role of BRCA1 or BRCA2 mutations in Ashkenazi Jewish families with hereditary prostate cancerThe Prostate, 39
T. Kirchhoff, N. Kauff, N. Mitra, K. Nafa, Helen Huang, C. Palmer, T. Gulati, E. Wadsworth, S. Donat, M. Robson, N. Ellis, K. Offit (2004)
BRCA Mutations and Risk of Prostate Cancer in Ashkenazi JewsClinical Cancer Research, 10
G. Jiang, W. Qu, H. Ruan, R. Burk (1995)
Elimination of false-positive signals in enhanced chemiluminescence (ECL) detection of amplified HPV DNA from clinical samples.BioTechniques, 19 4
N. Breslow, N. Day, W. Davis (1980)
Statistical methods in cancer research: volume 1- The analysis of case-control studiesIARC scientific publications, 32
D. Easton, D. Schaid, A. Whittemore, William Isaacs (2003)
Where are the prostate cancer genes?—A summary of eight genome wide searchesThe Prostate, 57
A. Willems, S. Dawson, H. Samaratunga, A. Luca, Y. Antill, J. Hopper, H. Thorne (2008)
Loss of Heterozygosity at the BRCA 2 Locus Detected byMultiplex Ligation-Dependent ProbeAmplification is Common in Prostate Cancers fromMenwith a Germline BRCA 2 Mutation
N. Loman, A. Bladström, O. Johannsson, Å. Borg, H. Olsson (2003)
Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation statusBreast Cancer Research, 5
E. Somers (1985)
International Agency for Research on Cancer.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 133 9
S. Zheng, Jielin Sun, F. Wiklund, Shelly Smith, P. Stattin, Ge Li, H. Adami, F. Hsu, Yi Zhu, K. Bälter, A. Kader, A. Turner, Wennuan Liu, E. Bleecker, D. Meyers, D. Duggan, J. Carpten, B. Chang, W. Isaacs, Jianfeng Xu, H. Grönberg (2008)
Cumulative association of five genetic variants with prostate cancer.The New England journal of medicine, 358 9
P. Lichtenstein, N. Holm, P. Verkasalo, A. Iliadou, J. Kaprio, J. Kaprio, M. Koskenvuo, M. Koskenvuo, E. Pukkala, A. Skytthe, K. Hemminki (2000)
Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland.The New England journal of medicine, 343 2
M. Freedman, C. Haiman, N. Patterson, G. McDonald, Arti Tandon, Alicja Waliszewska, K. Penney, R. Steen, K. Ardlie, E. John, I. Oakley-Girvan, A. Whittemore, K. Cooney, S. Ingles, D. Altshuler, B. Henderson, D. Reich (2006)
Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American menProceedings of the National Academy of Sciences, 103
C. Asperen, R. Brohet, E. Meijers-Heijboer, N. Hoogerbrugge, S. Verhoef, H. Vasen, M. Ausems, F. Menko, E. Garcia, J. Klijn, Frans Hogervorst, J. Houwelingen, L. Veer, M. Rookus, F. Leeuwen (2005)
Cancer risks in BRCA2 families: estimates for sites other than breast and ovaryJournal of Medical Genetics, 42
Roger Johnson, D. Kleinbaum, L. Kupper, K. Muller, A. Nizam (1999)
Applied Regression Analysis and Multivariable MethodsThe American Statistician, 53
J. Gudmundsson, P. Sulem, A. Manolescu, L. Amundadottir, D. Gudbjartsson, Agnar Helgason, T. Rafnar, J. Bergthorsson, B. Agnarsson, A. Baker, A. Sigurdsson, K. Benediktsdottir, Margret Jakobsdottir, Jianfeng Xu, T. Blondal, J. Kostic, Jielin Sun, Shyamali Ghosh, S. Stacey, Magali Mouy, Jona Saemundsdottir, V. Backman, K. Kristjánsson, A. Trés, A. Partin, M. Albers-Akkers, Javier Marcos, P. Walsh, D. Swinkels, Sebastian Navarrete, S. Isaacs, K. Aben, Theresa Graif, J. Cashy, M. Ruiz-Echarri, K. Wiley, B. Suarez, J. Witjes, M. Frigge, C. Ober, E. Jonsson, G. Einarsson, J. Mayordomo, L. Kiemeney, W. Isaacs, W. Catalona, R. Barkardottir, J. Gulcher, U. Thorsteinsdóttir, A. Kong, K. Stefánsson (2007)
Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24Nature Genetics, 39
NOTE: Missing values varied by mutation: BRCA1 185delAG (3 cases, 11 controls)
A. Vazina, J. Baniel, A. Shtriker, D. Engelstein, I. Leibovitch, M. Zehavi, T. Tishler, P. Livne, E. Friedman (1999)
THE PREVALENCE OF THE MAJOR "JEWISH MUTATIONS" BRCA1 AND BRCA2 IN PROSTATE CANCER PATIENTS IN ISRAELThe Journal of Urology
N. Hamel, K. Kotar, W. Foulkes (2003)
Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancerBMC Medical Genetics, 4
I. Agalliu, E. Kwon, Dan Zadory, Laura McIntosh, Joseph Thompson, J. Stanford, E. Ostrander (2007)
Germline Mutations in the BRCA2 Gene and Susceptibility to Hereditary Prostate CancerClinical Cancer Research, 13
M. Zeegers, A. Jellema, H. Ostrer (2003)
Empiric risk of prostate carcinoma for relatives of patients with prostate carcinomaCancer, 97
B. Friedenson (2004)
Re: BRCA1 and BRCA2 founder mutations and the risk of colorectal cancer.Journal of the National Cancer Institute, 96 15
S. Gayther, Karen Foy, P. Harrington, Paul Pharoah, W. Dunsmuir, S. Edwards, Cheryl Gillett, A. Ardern-jones, D. Dearnaley, D. Easton, D. Ford, R. Shearer, Roger Kirby, A. Dowe, Joanne Kelly, Michael Stratton, B. Ponder, Diana Barnes, R. Eeles (2000)
The frequency of germ-line mutations in the breast cancer predisposition genes BRCA1 and BRCA2 in familial prostate cancer. The Cancer Research Campaign/British Prostate Group United Kingdom Familial Prostate Cancer Study Collaborators.Cancer research, 60 16
F. Latif, K. Tory, J. Gnarra, M. Yao, F. Duh, M. Orcutt, T. Stackhouse, I. Kuzmin, W. Modi, L. Geil (1993)
Identification of the von Hippel-Lindau disease tumor suppressor gene.Science, 260 5112
J. Gudmundsson, P. Sulem, V. Steinthorsdottir, J. Bergthórsson, G. Thorleifsson, A. Manolescu, T. Rafnar, D. Gudbjartsson, B. Agnarsson, A. Baker, A. Sigurdsson, K. Benediktsdottir, Margret Jakobsdottir, T. Blondal, S. Stacey, Agnar Helgason, Steinunn Gunnarsdottir, A. Ólafsdóttir, Kari Kristinsson, B. Birgisdottir, Shyamali Ghosh, S. Thorlacius, D. Magnúsdóttir, G. Stefansdóttir, K. Kristjánsson, Y. Bagger, R. Wilensky, M. Reilly, A. Morris, Charlotte Kimber, A. Adeyemo, Yuanxiu Chen, Jie Zhou, W. So, P. Tong, M. Ng, T. Hansen, G. Andersen, K. Borch-Johnsen, T. Jørgensen, A. Trés, F. Fuertes, M. Ruiz-Echarri, L. Asín, B. Saez, Erica Boven, Siem Klaver, D. Swinkels, K. Aben, Theresa Graif, J. Cashy, B. Suarez, Onco Trip, M. Frigge, C. Ober, M. Hofker, C. Wijmenga, C. Christiansen, D. Rader, C. Palmer, C. Rotimi, J. Chan, O. Pedersen, G. Sigurdsson, R. Benediktsson, E. Jonsson, G. Einarsson, J. Mayordomo, W. Catalona, L. Kiemeney, R. Barkardottir, J. Gulcher, U. Thorsteinsdóttir, A. Kong, K. Stefánsson (2007)
Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetesNature Genetics, 39
H. Olsson (1999)
Cancer risks in BRCA2 mutation carriers.Journal of the National Cancer Institute, 91 15
Cancer Epidemiology, Biomarkers and Prevention – Unpaywall
Published: Feb 1, 2009
Access the full text.
Sign up today, get DeepDyve free for 14 days.